VF
CANF

Virtu Financial’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Virtu Financial’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,908
Closed -$40K – 1651
2026
Q1 		$40K Buy
+12,908
New +$53.4K ﹤0.01% 1319
2025
Q2 		– Sell
-687
Closed -$20K – 1511
2025
Q1 		$20K Buy
+687
New +$21.9K ﹤0.01% 1104
2024
Q3 		– Sell
-521
Closed -$27K – 1420
2024
Q2 		$27K Buy
+521
New +$24.6K ﹤0.01% 994
2022
Q4 		– Sell
-144
Closed -$22K – 1660
2022
Q3 		$22K Sell
144
-138
-49% -$23.9K ﹤0.01% 1372
2022
Q2 		$52K Buy
+282
New +$54.1K ﹤0.01% 1114
2021
Q2 		– Sell
-231
Closed -$114K – 1547
2021
Q1 		$114K Sell
231
-139
-38% -$60.3K 0.01% 1282
2020
Q4 		$132K Buy
370
+302
+444% +$110K 0.01% 984
2020
Q3 		$24K Sell
68
-91
-57% -$38K ﹤0.01% 906
2020
Q2 		$63K Buy
+159
New +$58.5K 0.01% 976
2018
Q4 		– Sell
-9
Closed -$35K – 1583
2018
Q3 		$35K Buy
+9
New +$33.7K ﹤0.01% 1350
2018
Q1 		– Sell
-7
Closed -$29K – 1998
2017
Q4 		$29K Buy
7
+3
+75% +$13.7K ﹤0.01% 2165
2017
Q3 		$19K Buy
+4
New +$20.6K ﹤0.01% 2356

Other funds holding CANF

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial's CANF Position: Q2 2026 in Review

Virtu Financial sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2026, closing a stake of 12,908 shares — an estimated $40K sold.

Virtu Financial first reported a position in CANF in Q3 2017 and held it in 12 quarters. The position peaked at $132K in Q4 2020. 8 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

  • Virtu Financial reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 12,908 Can-Fite BioPharma American Depositary Shares shares in Q2 2026, an estimated $40K.
  • Virtu Financial first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's Can-Fite BioPharma American Depositary Shares position peaked at $132K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.